Sabra Healthcare REIT (NASDAQ:SBRA) Receives Underperform Rating from Raymond James Financial

Sabra Healthcare REIT (NASDAQ:SBRA)‘s stock had its “underperform” rating reaffirmed by equities research analysts at Raymond James Financial in a research note issued on Wednesday, MarketBeat.com reports.

Several other brokerages have also commented on SBRA. Wells Fargo & Company raised their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Citigroup boosted their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. UBS Group increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Truist Financial raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. Finally, Citizens Jmp lifted their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Five investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $22.40.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock traded down $0.09 during trading on Wednesday, hitting $18.47. 79,492 shares of the stock were exchanged, compared to its average volume of 2,587,025. The stock’s fifty day moving average is $20.01 and its 200 day moving average is $19.68. The stock has a market cap of $4.66 billion, a PE ratio of 29.32, a P/E/G ratio of 1.38 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a 12 month low of $17.17 and a 12 month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The firm had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period last year, the firm posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT will post 1.51 EPS for the current year.

Institutional Trading of Sabra Healthcare REIT

Large investors have recently added to or reduced their stakes in the business. Rothschild Investment LLC grew its position in Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth $28,000. Strengthening Families & Communities LLC acquired a new position in shares of Sabra Healthcare REIT in the 4th quarter worth $29,000. Finally, Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT during the third quarter worth $30,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.